CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock OTC
- 4 Open-market sale President and CEO sold 1,257 shares at $6.43 ($8,083)
- 4 Open-market sale SVP, General Counsel&Secretary sold 234 shares at $6.43 ($1,505)
- 4 Open-market sale EVP, Chief Development Officer sold 401 shares at $6.43 ($2,578)
- 4 Open-market sale EVP & Chief Medical Officer sold 408 shares at $6.43 ($2,623)
- 4 Open-market sale EVP & Chief Commercial Officer sold 325 shares at $6.43 ($2,090)
- 4 Open-market sale Chief Accounting Officer sold 23 shares at $6.43 ($148)
- 4 Open-market sale Chief Accounting Officer sold 12 shares at $6.78 ($81)
- 4 Open-market sale EVP, Chief Development Officer sold 191 shares at $4.37 ($835)
- 4 Open-market sale Chief Accounting Officer sold 238 shares at $4.00 ($952)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 236 shares at $7.12 ($1,680)
- 4 Open-market sale EVP & Chief Medical Officer sold 419 shares at $6.17 ($2,585)
- 4 Open-market sale President and CEO sold 245 shares at $3.74 ($916)
- 4 Open-market sale EVP & Chief Commercial Officer sold 3,445 shares at $6.29 ($21,669)
Page 3 of 31 · 601 filings